John Valliant
Founder bij FUSN PHAR
Vermogen: 7 M $ op 31-03-2024
Profiel
John Valliant is the founder of Fusion Pharmaceuticals, Inc. (2014) and Centre For Probe Development & Commercialization (2008), where he holds the titles of Chief Executive Officer & Director and Independent Director & Principal Investigator, respectively.
He is currently a Professor at McMaster University, a position he has held since 1999.
Dr. Valliant earned a doctorate degree from McMaster University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
04-01-2024 | 318 147 ( 0.38% ) | 7 M $ | 31-03-2024 |
Actieve functies van John Valliant
Bedrijven | Functie | Begin |
---|---|---|
FUSN PHAR | Founder | 01-12-2014 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Founder | 01-03-2008 |
McMaster University | Corporate Officer/Principal | 01-01-1999 |
Opleiding van John Valliant
McMaster University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
FUSN PHAR | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Health Technology |